LOGO
LOGO

Intraday Alerts

SciSparc Soars 149% After CliniQuantum Acquisition Approval

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of SciSparc Ltd. (SPRC) surged after the company announced its subsidiary, NeuroThera Labs Inc., received conditional regulatory approval for its acquisition of CliniQuantum Ltd.The stock is currently trading at $10.94, up $6.54 or 148.64%, on the Nasdaq. It opened at $13.22 after closing the previous session at $4.40. The stock has traded between $2.98 and $80.10 over the past 52 weeks. Un...

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19